SCHEMBL14201368

SCHEMBL14201368

C=Cc1cc(C)ccc1NN

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.36
TP53 P04637 2/20 0.36
RAPGEF4 Q8WZA2 1/20 0.34
HPGD P15428 1/20 0.32
CYP3A4 P08684 1/20 0.32
THRB P10828 1/20 0.32
ALOX15 P16050 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ALDH1A1 P00352 2/20 0.31
CYP1A2 P05177 3/20 0.31
CYP2A6 P11509 2/20 0.31
KDM4E B2RXH2 2/20 0.30
HTT P42858 2/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
ALOX5 P09917 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13886805 0.84 TDP1 (0.36) TDP1TP53RAPGEF4HPGDCYP3A4
SCHEMBL14100633 0.82 TDP1 (0.38) TDP1TP53RAPGEF4HPGDSMN1; SMN2
SCHEMBL19432185 0.80 TDP1 (0.36) TDP1TP53RAPGEF4HPGDMEN1
SCHEMBL7790391 0.80 SRC (0.43) RAPGEF4HPGDMEN1KMT2AALDH1A1
SCHEMBL20161244 0.77 CYP3A4 (0.38) TDP1TP53RAPGEF4HPGDCYP3A4
SCHEMBL14201220 0.76 TRPA1 (0.34) HPGDSMN1; SMN2ALDH1A1CYP1A2CYP2A6
SCHEMBL5084622 0.73 TDP1 (0.44) TDP1TP53HPGDCYP3A4THRB
SCHEMBL21312635 0.73 RAPGEF4 (0.41) TDP1TP53RAPGEF4SMN1; SMN2MEN1
SCHEMBL13363012 0.72 TDP1 (0.52) TDP1TP53CYP3A4THRBALOX15
SCHEMBL21323393 0.72 UTS2R (0.43) TDP1CYP3A4ALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018132279-A1 TGF BETA RECEPTOR ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-07-19 WO disclosed
WO-2018017633-A1 TGF Beta RECEPTOR ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-25 WO disclosed
EP-1465900-B1 RHO-KINASE INHIBITORS BAYER HEALTHCARE AG (DE) 2008-05-14 EP disclosed